180 related articles for article (PubMed ID: 37129114)
1. Impaired neurocognitive functioning 3 months following diagnosis of high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group.
Hardy KK; Kairalla JA; Gioia AR; Weisman HS; Gurung M; Noll RB; Hinds PS; Hibbitts E; Salzer WL; Burke MJ; Winick NJ; Embry L
Pediatr Blood Cancer; 2023 Jul; 70(7):e30350. PubMed ID: 37129114
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
Sands SA; Harel BT; Savone M; Kelly K; Vijayanathan V; Welch JG; Vrooman L; Silverman LB; Cole PD
Support Care Cancer; 2017 Feb; 25(2):449-457. PubMed ID: 27726029
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of serial neurocognitive assessment using Cogstate during and after therapy for childhood leukemia.
Cole PD; Kim SY; Li Y; Schembri A; Kelly KM; Sulis ML; Vrooman L; Welch JJG; Ramjan S; Silverman LB; Sands SA
Support Care Cancer; 2023 Jan; 31(2):109. PubMed ID: 36625831
[TBL] [Abstract][Full Text] [Related]
4. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
[TBL] [Abstract][Full Text] [Related]
5. Association between fatigue and sleep disturbances during treatment for pediatric acute lymphoblastic leukemia and posttreatment neurocognitive performance.
Vasquez P; Escalante J; Raghubar KP; Kahalley LS; Taylor OA; Moore IK; Hockenberry MJ; Scheurer ME; Brown AL
Pediatr Blood Cancer; 2022 May; 69(5):e29507. PubMed ID: 34889514
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E
Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396
[TBL] [Abstract][Full Text] [Related]
7. Preserved executive functioning and low stress symptoms in children treated for acute lymphoblastic leukemia.
Godoy PBG; Mello CB; Pompéia S; da Costa CML; Cypriano MDS; Suchecki D
Appl Neuropsychol Child; 2022; 11(3):270-279. PubMed ID: 32787697
[TBL] [Abstract][Full Text] [Related]
8. Working memory training in survivors of pediatric cancer: a randomized pilot study.
Hardy KK; Willard VW; Allen TM; Bonner MJ
Psychooncology; 2013 Aug; 22(8):1856-65. PubMed ID: 23203754
[TBL] [Abstract][Full Text] [Related]
9. The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.
Kunin-Batson A; Kadan-Lottick N; Neglia JP
Psychooncology; 2014 Jun; 23(6):692-9. PubMed ID: 24497266
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
[TBL] [Abstract][Full Text] [Related]
11. Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331.
Mitchell HR; Lu X; Myers RM; Sung L; Balsamo LM; Carroll WL; Raetz E; Loh ML; Mattano LA; Winick NJ; Devidas M; Hunger SP; Maloney K; Kadan-Lottick NS
Int J Cancer; 2016 Jan; 138(2):332-9. PubMed ID: 26235006
[TBL] [Abstract][Full Text] [Related]
12. Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
Liu W; Cheung YT; Conklin HM; Jacola LM; Srivastava D; Nolan VG; Zhang H; Gurney JG; Huang IC; Robison LL; Pui CH; Hudson MM; Krull KR
J Cancer Surviv; 2018 Jun; 12(3):398-406. PubMed ID: 29484542
[TBL] [Abstract][Full Text] [Related]
13. Everyday executive function in standard-risk acute lymphoblastic leukemia survivors.
Walsh KS; Paltin I; Gioia GA; Isquith P; Kadan-Lottick NS; Neglia JP; Brouwers P
Child Neuropsychol; 2015; 21(1):78-89. PubMed ID: 24428397
[TBL] [Abstract][Full Text] [Related]
14. Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group.
Dupuis LL; Lu X; Mitchell HR; Sung L; Devidas M; Mattano LA; Carroll WL; Winick N; Hunger SP; Maloney KW; Kadan-Lottick NS
Cancer; 2016 Apr; 122(7):1116-25. PubMed ID: 26773735
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Trajectories of Neurocognitive Functioning in Childhood Acute Lymphoblastic Leukemia.
Partanen M; Phipps S; Russell K; Anghelescu DL; Wolf J; Conklin HM; Krull KR; Inaba H; Pui CH; Jacola LM
J Pediatr Psychol; 2021 Feb; 46(2):168-178. PubMed ID: 33011782
[TBL] [Abstract][Full Text] [Related]
16. Cognitive and behavioral risk factors for low quality of life in survivors of childhood acute lymphoblastic leukemia.
van der Plas E; Spencer Noakes TL; Butcher DT; Weksberg R; Galin-Corini L; Wanstall EA; Te P; Hopf L; Guger S; Hitzler J; Schachar RJ; Ito S; Nieman BJ
Pediatr Res; 2021 Aug; 90(2):419-426. PubMed ID: 33203967
[TBL] [Abstract][Full Text] [Related]
17. Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures.
Van Der Plas E; Erdman L; Nieman BJ; Weksberg R; Butcher DT; O'connor DL; Aufreiter S; Hitzler J; Guger SL; Schachar RJ; Ito S; Spiegler BJ
Child Neuropsychol; 2018 Nov; 24(8):999-1014. PubMed ID: 29017430
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological outcome in chemotherapy-only-treated children with acute lymphoblastic leukemia.
Jansen NC; Kingma A; Schuitema A; Bouma A; Veerman AJ; Kamps WA
J Clin Oncol; 2008 Jun; 26(18):3025-30. PubMed ID: 18565888
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive Functioning of Children Treated for High-Risk B-Acute Lymphoblastic Leukemia Randomly Assigned to Different Methotrexate and Corticosteroid Treatment Strategies: A Report From the Children's Oncology Group.
Hardy KK; Embry L; Kairalla JA; Helian S; Devidas M; Armstrong D; Hunger S; Carroll WL; Larsen E; Raetz EA; Loh ML; Yang W; Relling MV; Noll RB; Winick N
J Clin Oncol; 2017 Aug; 35(23):2700-2707. PubMed ID: 28671857
[TBL] [Abstract][Full Text] [Related]
20. Impact of sleep, fatigue, and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia.
Cheung YT; Brinkman TM; Mulrooney DA; Mzayek Y; Liu W; Banerjee P; Panoskaltsis-Mortari A; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
Cancer; 2017 Sep; 123(17):3410-3419. PubMed ID: 28452142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
